prostate cancer vaccine in Germany
Immunotherapy of prostate cancer: prospects for vaccine prevention and treatment
Immunotherapy for prostate cancer is a breakthrough in oncology that uses the patient’s own immune system to fight the tumor. RheinRegio Klinik Zentrum uses the latest vaccine technologies that have passed international clinical trials and shown to be highly effective with minimal side effects.
Indications for vaccine therapy
- Metastatic castration-resistant cancer
- Combination with hormonal therapy
- Recurrent forms after surgery
- Palliative treatment for progression
Contraindications
- Autoimmune diseases in active phase
- Severe immunodeficiency
- Allergy to vaccine components
Each direction is supervised by advanced oncologists.
Find out the cost of treatment
To find out the approximate cost of treatment, answer a few questions and we will contact you!
Treatment methods
Accurate diagnosis
- Tumor genomic testing
- Assessment of PD-L1 status
- PET-PSA for detection of metastases
Individual protocol
- Selection of a vaccine by molecular profile
- Combinations with:
- Checkpoint inhibitors
- Radiotherapy
- Targeted drugs
- Checkpoint inhibitors
Response monitoring
- Circulating DNA analysis
- Immunological markers
- Dynamic PET-CT
Prospects
- Neoadjuvant use before surgery
- Relapse Prevention
- Combinations with CAR-T therapy
Vaccine therapy for prostate cancer in Germany is an individually tailored treatment that activates the body’s natural defense mechanisms. The RheinRegio Klinik Zentrum offers access to the most modern protocols, including experimental methods in clinical trials.
For consultation:
Provide histology data and results of recent PSA tests
Our clinics
The association of clinics RheinRegio Klinik Zentrum offers the organization of prostate cancer vaccines in Germany without intermediaries, providing access to the country’s leading oncology clinics. We combine advanced techniques, an individual approach and the highest level of medical care, giving hope even in difficult cases.
Why RheinRegio Klinik Zentrum?
- Participation in international studies (NCT04382898, NCT02649439)
- Own cell technology laboratory
- A team of oncoimmunologists with 15 years of experience
- Personalized approach to each patient
